Literature DB >> 18607021

Colloidal silver for lung disease in cystic fibrosis.

V R Baral1, A L Dewar, G J Connett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18607021      PMCID： PMC2443992          DOI： 10.1258/jrsm.2008.s18012

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

Review 1.  Critical observations on the neurotoxicity of silver.

Authors:  A B G Lansdown
Journal:  Crit Rev Toxicol       Date:  2007-03       Impact factor: 5.635

2.  Case report: skin discoloration following administration of colloidal silver in cystic fibrosis.

Authors:  Christopher D Baker; Monica J Federico; Frank J Accurso
Journal:  Curr Opin Pediatr       Date:  2007-12       Impact factor: 2.856

3.  Generalized argyrosis in man: neurotological, ultrastructural and X-ray microanalytical findings.

Authors:  M Westhofen; H Schäfer
Journal:  Arch Otorhinolaryngol       Date:  1986

4.  Silver against Pseudomonas aeruginosa biofilms.

Authors:  Thomas Bjarnsholt; Klaus Kirketerp-Møller; Søren Kristiansen; Richard Phipps; Anne Kirstine Nielsen; Peter Østrup Jensen; Niels Høiby; Michael Givskov
Journal:  APMIS       Date:  2007-08       Impact factor: 3.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.